These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 5536636

  • 21. [Oral administration of bencyclane].
    Okos G, Czeglédy A.
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1421+. PubMed ID: 5536659
    [No Abstract] [Full Text] [Related]

  • 22. [Effect of bencyclane on normal blood pressure and on experimental hypertension].
    Rigó J, Szelenyi I.
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1371+. PubMed ID: 5536642
    [No Abstract] [Full Text] [Related]

  • 23. [Cerebral circulation processes under the influence of bencyclane].
    Klausberger E, Rajna P.
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1457+. PubMed ID: 5536672
    [No Abstract] [Full Text] [Related]

  • 24. [Comparative experimental study on the effect of bencyclane in drivers].
    Horváth LG.
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1455+. PubMed ID: 5536671
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Investigation of the absorption, distribution, and elimination of bencyclane with radioactive isotopes. Preliminary report.
    Blasko K.
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1374+. PubMed ID: 5536644
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Effect of bencyclan (Fludilat) on the vascularization of extremity arteries in the animal experiment].
    Schmitt G, Sczuka C.
    Verh Dtsch Ges Inn Med; 1974 Oct; 80():960-3. PubMed ID: 4454702
    [No Abstract] [Full Text] [Related]

  • 31. [The metabolites of bencyclane].
    Gyarmati L, Máté L.
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1387+. PubMed ID: 5536649
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacoradiographic examination of antispasmodics.
    Gimes B.
    Ther Hung; 1971 Oct; 19(4):156-61. PubMed ID: 5146137
    [No Abstract] [Full Text] [Related]

  • 34. Tiapamil, a new calcium antagonist. 2. Further pharmacological characterization and toxicology.
    Eigenmann R, Gerold M, Hefti F, Jovanovic D, Haeusler G.
    Arzneimittelforschung; 1981 Oct; 31(9):1401-10. PubMed ID: 7197946
    [No Abstract] [Full Text] [Related]

  • 35. [Absorption, distribution and elimination of radioactively labelled bencyclane].
    Nagy J, Blaskó K.
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1376+. PubMed ID: 5536645
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Spasmolytic and antiemetic effect of aklonin (DL-phenyl-alpha-aminoacetic acid isoamyl ester) and its elimination].
    Schulz E, Sprung WD, Wiegershausen B, Sosat R.
    Pharmazie; 1970 Sep; 25(9):560-5. PubMed ID: 4395041
    [No Abstract] [Full Text] [Related]

  • 39. [Additional pharmacologic studies on the EGYT-201 compound (Halidor)].
    Kovács I.
    Orv Hetil; 1968 May 26; 109(21):Suppl:12-4. PubMed ID: 5720712
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.